Dec 8 (Reuters) – Structure Therapeutics said on Monday that its obesity pill showed a 11.3% reduction in weight in a mid-stage study.

Shares of the biotech jumped 41.8% in premarket trading.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shailesh Kuber)

See Full Page